Abstract
BACKGROUND: Obesity is associated with a higher incidence of colorectal cancer and increased colorectal cancer mortality. Obese women are less likely to undergo breast and cervical cancer screening than nonobese women. It is not known whether obesity is associated with a lower likelihood of colorectal cancer screening.
OBJECTIVE: To evaluate whether there is an association between body mass index (BMI) and rates of colorectal cancer screening. To examine whether BMI-related disparities in colorectal cancer screening differ between men and women.
DESIGN AND SETTING: The Behavioral Risk Factor Surveillance System, a cross-sectional random-digit telephone survey of noninstitutionalized adults conducted by the Centers for Disease Control and Prevention and state health departments in the 50 states and Washington, DC in 1999.
PATIENTS: Survey respondents (N=52,886) between 51 and 80 years of age representing 64,563,332 U.S. adults eligible for colorectal cancer screening.
INTERVENTIONS AND MEASURMENTS: Adjusted rates of self-reported colorectal cancer screening with fecal occult blood testing within the past year or endoscopic screening (sigmoidoscopy or colonoscopy) within the past 5 years.
RESULTS: The colorectal cancer screening rate was 43.8% overall. The rate of screening by FOBT within the last year or endoscopic screening within the past 5 years was 39.5% for the morbidly obese group, 45.0% for the obese group, 44.3% for the overweight group, and 43.5% for the normal weight group. The difference in screening rates was entirely attributable to differences in BMI among women. After statistical adjustment for potential confounders, morbidly obese women were less likely than normal weight women to be screened (adjusted rate difference, −5.6%; 95% confidence interval, −8.5 to −2.6). Screening rates among normal weight, overweight, and obese women, and among men in different weight groups did not differ significantly.
CONCLUSIONS: Colorectal cancer screening rates among age-eligible persons in the U.S. are disturbingly low. Morbidly obese women, who are at higher risk than others to develop and to die from colorectal cancer, are less likely to be screened. Efforts to increase colorectal cancer screening are needed for all age-eligible groups, but should also include targeted screening of morbidly obese women since they could reap substantial clinical benefits from screening.
Similar content being viewed by others
References
American Cancer Society. Cancer facts & figures 2002. Available at: http://www.cancer.org. Accessed May 29, 2002.
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.
Mandel JS, Oken M. Etiology, prevention, and treatment of breast, prostate, colorectal, and lung cancer. Minn Med. 1998;81:44–6, 71.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet. 1996;348:1467–71.
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–5.
Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case control study of 32,702 veterans. Ann Intern Med. 1995;123:904–10.
Selby J, Friedman G, Quesenberry JCP, Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Eng J Med. 1992;326:653–62.
Kavanaugh A, Giovannucci E, Fuchs C, et al. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control. 1998;9:455–62.
Centers for Disease Control and Prevention (CDC). Trends in screening for colorectal cancer, U.S., 1997 and 1999. Morb Mortal Wkly Rep. 2001;50:162–6.
Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–22.
Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;16:1581–6.
Martinez ME, Giovannucci E, Spiegelman D, Hunter DJ, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. Nurses’ Health Study Research Group. J Natl Cancer Inst. 1997;89:948–55.
Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–34.
Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry CP, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998;22:178–84.
Ford ES. Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol. 1999;150:390–8.
LeMarchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 1997;57:4787–94.
Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–30.
Tomeo C, Colditz G, Willett W, et al. Harvard Report on Cancer Prevention, 3: Prevention of Colon Cancer in the United States. Harvard Center for Cancer Prevention, Harvard School of Public Health, Harvard University, Boston, Mass; 1999:167–80.
Murphy TK, Calle EE, Rodriquez C, Khan HS, Thun MJ. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol. 2000;152:847–54.
Shike M. Body weight and colon cancer. Am J Clin Nutr. 1996;63(suppl):442–4S.
Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–200.
Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med. 2000;132:697–704.
Fontaine KR, Faith MS, Allison DB, Cheskin LJ. Body weight and health care among women in the general population. Arch Fam Med. 1998;7:381–4.
Adams CH, Smith NJ, Wilbur DC, Grady KE. The relationship between obesity to the frequency of pelvic examinations: do physician and patient attitudes make a difference? Women Health. 1993;20:45–57.
Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Website. Available at: http://www.cdc.gov/brfss. Accessed May 29, 2002.
Centers for Disease Control and Prevention (CDC) 1999 BRFSS Summary Quality Control Report. Available at: http://www.cdc.gov/brfss/pdf/99quality.pdf. Accessed May 29, 2002.
United States Preventive Service Task Force. Guide to Clinical Preventive Services: Report of the U.S. Preventive Services Task Force, 3rd ed. Washington, DC: U.S. Government Printing Office, July 2002.
Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.
Anonymous. American Gastroenterology Association issues guidelines for colorectal cancer screening. Am Fam Physician. 1997;55:2860–5.
World Health Organization (WHO) Consultation on Obesity. Obesity epidemic puts millions at risk from related diseases. Available at: http://www.who./int/en/. Accessed June 19, 2002.
Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA. 2000;284:2061–9.
Little RJA. Direct standardization: a tool for teaching linear models for unbalanced data. Am Stat. 1982;36:38–43.
Frane J. SUDAAN. Professional Software for Survey Data Analysts. Research Triangle Park, NC: Research Triangle Institute; 1989.
LaVange LM, Stearns SC, Lafata JE, Koch GG, Shah BV. Innovative strategies using SUDAAN for analysis of health surveys with complex samples. Stat Meth Med Res. 1996;5:311–29.
Schroy PC III, Geller AC, Crosier Wood MC, et al. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev Med. 2001;33:381–91.
McMahon LF Jr, Wolfe RA, Huang S, Tedeschi P, Manning W Jr, Edlund MJ. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care. 1999;37:712–7.
U.S. Department of Health and Human Services, Healthy People 2010. Available at: http://www.health.gov/healthypeople/. Accessed June 27, 2002.
Shapiro JA, Seef LC, Nadel M. Colorectal cancer screening tests and associated health behaviors. Am J Prev Med. 2001;21:132–7.
Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health. 2001;91:1264–72.
Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med. 1993;329:1008–12.
Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone. 1999;2:17–31.
Kiefe CI, Funkhouser E, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13:357–65.
Maddox GL, Back K, Liederman V. Overweight as social deviance and disability. J Health Soc Behav. 1968;9:287–98.
Maddox GL, Liederman V. Overweight as a social disability with medical implications. J Med Educ. 1969;44:214–20.
Blumberg P, Mellis LP. Medical students’ attitudes toward the obese and the morbidly obese. Int J Eat Disord. 1980;4:169–75.
Young LM, Powell B. The effects of obesity on the clinical judgments of mental health professionals. J Health Soc Behav. 1985;26:233–46.
Price JH, Desmond SM, Krol RA, Snyder FF, O’Connell JK. Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prev Med. 1987;3:339–45.
Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119(suppl 7):655–60.
Montano D, Phillips W. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85:795–800.
Mandelson M, LaCroix A, Anderson L, Nadel M, Lee N. Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization. Am J Epidemiol. 1999;150:617–21.
Palta M, Prineas RJ, Berman R, Hannan P. Comparison of self-reported and measured height and weight. Am J Epidemiol. 1982;115:223–30.
Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Sozial- und Praventivmedizin. 2001;46(suppl 1):S3–42.
U.S. Census Bureau. Statistical abstract of the United States, 2001. Available at: http://www.census.gov/prod/2002pubs/01statab/tele.pdf. Accessed June 20, 2002.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was presented at the 2002 annual national meeting of the Society of General Internal Medicine.
Dr. Rosen was supported by an AHRQ Health Services Research Fellowship at the Harvard School of Public Health, grant number 5 T32 HS00020-16.
Rights and permissions
About this article
Cite this article
Rosen, A.B., Schneider, E.C. Colorectal cancer screening disparities related to obesity and gender. J GEN INTERN MED 19, 332–338 (2004). https://doi.org/10.1111/j.1525-1497.2004.30339.x
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2004.30339.x